Is CLDI or CLYM more undervalued in 2026?

CirclFi compares Calidi Biotherapeutics, Inc. (CLDI) and Climb Bio, Inc. (CLYM) using 13 institutional-grade valuation models. CLDI has a Quality of Company score of 4.2/10 while CLYM scores 4.1/10.

Which is a better buy — CLDI or CLYM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CLDI and CLYM valuations compare?

CLDI at $0.19 and CLYM at $11.34 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CLDI vs CLYM Valuation Comparison 2026 — Intrinsic Value Analysis

CLDI

Biotechnology

Calidi Biotherapeutics, Inc.

Quality

4.2

out of 10

Value Trap

LOW

Price

$0.19

Last close

Models

6/13

Active

CLYM

Biotechnology

Climb Bio, Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$11.34

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	CLDI Fair Value	CLDI Upside	CLYM Fair Value	CLYM Upside
Bayesian DCF	Intrinsic	$0.18	-7.4%	$3.12	-72.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.04	+448.0%	$0.84	-92.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CLDI vs CLYM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CLDI vs CLYM — Which Stock Is More Undervalued?

CLDI scores higher with a 4.2/10 quality rating vs CLYM's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Calidi Biotherapeutics, Inc. (CLDI) and Climb Bio, Inc. (CLYM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CLDI currently trades at $0.19 with a QOC of 4.2/10, while CLYM trades at $11.34 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).